ACPP anticorps

N° du produit ABIN238332

Cet anticorps anti-ACPP est un anticorps Souris Monoclonal détectant ACPP dans FACS et cELISA. Adapté pour Humain.

Aperçu rapide pour ACPP anticorps (ABIN238332)

Antigène: ACPP (Acid Phosphatase, Prostate (ACPP))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp ACPP est non-conjugé

Application: Flow Cytometry (FACS), Cell-ELISA (cELISA)

Clone: LT-3D1

Détail du produit anti-ACPP anticorps

Purification: Protein G

Immunogène: genetic immunisation with cDNA encoding human PAP

Isotype: IgG1

Information d'application

Indications d'application: Flow cytometry: 1.2 µg/10^6 cells
CELISA: 1:200 - 1:400
For each application a titration should be performed to determine the optimal concentration.

Restrictions: For Research Use only

Stockage

Concentration: 2 mg/mL

Buffer: PBS, pH 7.2

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C

Stockage commentaire: short term: 2 °C - 8 °C, long term: -20 °C

Détails sur ACPP

Antigène: ACPP (Acid Phosphatase, Prostate (ACPP))

Autre désignation: PAP

Sujet: Human prostatic acid phosphatase (PAP) is a non-specific phosphomonoesterase, synthesised and secreted into seminal plasma under androgenic control. Human PAP is a 100 kDa glycoprotein containing two subunits of approximately 50 kDa each. It catalyses the dephosphorylation of organic monophosphate esters, demonstrating optimum activity at an acid pH. Produced by the prostatic epithelium, serum levels of PAP are very low in healthy individuals, but are often elevated in malignant and benign prostatic disease while it has been used as a marker of diagnosis and therapy control of cancer of the prostate gland.

UniProt: P15309

Pathways: Synaptic Membrane, Ribonucleoside Biosynthetic Process